11/07/2013 18:45:00

U.K. Recalls Drugs Made in India

LONDON--In another sign of possible manufacturing problems in India's pharmaceutical industry, the U.K.'s medicines regulator said it was recalling 16 drugs made by Wockhardt Ltd. (532300.BY) after finding "manufacturing deficiencies" at one of the company's factories in India.

The Medicines and Healthcare products Regulatory Agency, or MHRA, called it a "precautionary recall," as there is no evidence that the medicines are defective. The agency said it is recalling the drugs from pharmacies and wholesalers but isn't asking patients to return their Wockhardt medicines.

"There is no evidence of a patient safety risk. ...however, the MHRA has to act in the interest of public health as poor manufacturing standards cannot be allowed to continue," the agency said.

The recalled drugs, manufactured in the central Indian city of Waluj, include treatments for infections, hypertension, diabetes, epilepsy and other diseases. The MHRA said the plant suffered from "poor cleaning practices" and defective ventilation systems. The agency inspection also found evidence of "forged documents relating to staff training records."

In an emailed statement, Wockhardt confirmed the news and said the recall would result in a one-time charge of 1.5 million pounds ($2.25 million) this year. Exports from the Waluj plant constitute less than 5% of the company's total U.K. sales and less than 2% of overall sales, it added.

It was the second recent setback for the company and its Waluj factory. In May, the U.S. Food and Drug Administration imposed an import ban on products from the factory after it failed an FDA safety inspection. The FDA didn't elaborate on the problems it found.

In a conference call at the time, Wockhardt Chairman Habil Khorakiwala said the company was implementing "corrective measures to be in compliance with the FDA guidelines." He said the U.S. import ban could cost the company $100 million in revenue this fiscal year. Wockhardt generated total revenue of 25.6 billion rupees ($460.6 million) in the year ended March 31, 2012.

Also in May, India's Ranbaxy Laboratories Ltd. (500359.BY) agreed to pay $500 million in civil and criminal fines for exporting adulterated drugs to the U.S.

In a phone interview Thursday, D.G. Shah, secretary-general of the Indian Pharmaceutical Alliance, an industry body, said the group has written to the FDA asking it to conduct workshops with Indian companies to correct erroneous practices.

"Companies need to better understand FDA processes, and there needs to be a correction in their organizational culture, right from drug discovery to development and production," Mr. Shah said.

Write to Jeanne Whalen at jeanne.whalen@wsj.com and Anirban Chowdhury at anirban.chowdhury@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 11, 2013 13:45 ET (17:45 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
25 Aug
GEN
Stop nu det mobberi GW   Jeg elsker at følge den aktie, og det er så trist at du altid skal hævde di..
23
24 Aug
FING-B
Sig mig.. har du slet ingen skam i livet !!.. du stjæler ENDNU ENGANG et skriv fra en anden skribent..
22
26 Aug
FING-B
Når Nordea alene i deres analyse tager udgangspunkt i konkurrencesituationen flere år fremme i tiden..
18
23 Aug
BAVA
Bavarian Nordic har sammen med Crucell og div. myndigheder igangsat to interessante nye forsøg med M..
18
24 Aug
ZEAL
I Solothum uden for Bern i Svejts ligger en fabrik, hvor der er blevet investeret 50 mio CHF det sen..
17
23 Aug
 
http://borsen.dk/nyheder/politik/artikel/1/330221/opgoerelse_viser_nye_milliarder_tabt_til_skattesvi..
15
21 Aug
ZEAL
Bølgerne har gået højt her på EI’s forum siden Sanofi fredag oplyst at et mere endeligt svar på sags..
15
23 Aug
DANSKE
Tro ikke på 6212 han er blot en bondeknold, der efterhånden er gået kold arme stakkels lille trold, ..
14
25 Aug
ZEAL
Her kommer endnu et bud på, hvor Zealand skal hen efter en FDA godkendelse af iGlarlixi. Jeg siger k..
13
25 Aug
GEN
Sådan ser jeg det bestemt heller ikke !! GW har hele tiden, på hans helt egen facon, stået ved at ha..
12

Alliance Trust PLC : Net Asset Value(s)

26/08/2016 15:36:16
ALLIANCE TRUST PLC                                    At the close of business on Thursday 25 August 2016: The Company's NAV per ordinary shar..

HSBC Bank Plc : Form 8.5 (EPT/RI) - London Stock Exchange Group Plc

26/08/2016 11:44:22
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY ..

OZ Management LP : Form 8.3 - Home Retail Group Plc

26/08/2016 10:51:16
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
New Long-Term Data Reinforce Safety Benefits of the World's Smallest Pacemaker
2
Eckert & Ziegler BEBIG: Eckert & Ziegler buys Belgian provider of brachytherapy accessories

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2016   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
28 August 2016 17:35:27
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20160826.1 - EUROWEB3 - 2016-08-28 18:35:27 - 2016-08-28 17:35:27 - 1000 - Website: OKAY